We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Advisors Recommend Gilead, Janssen-Cilag Cancer Drugs, Allergan Eye Treatment
EU Advisors Recommend Gilead, Janssen-Cilag Cancer Drugs, Allergan Eye Treatment
A key European advisory panel gave positive opinions for Gilead’s Zydelig and Janssen-Cilag’s Imbruvica to treat various forms of rare blood cancers and a new indication for Allergan’s Ozurdex to treat the eye disorder diabetic macular edema.